Betting on biotech: Innovation and the limits of Asia's developmental state

Betting on Biotech: Innovation and the Limits of Asia's Developmental State

Volumn , Issue , 2011, Pages 1-200

  Wong, Joseph ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85055600348     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (203)

1. Gary Pisano, Science Business: The Promise, the Reality and the Future of Biotech (Boston: Harvard Business School Press, 2006), 112.
2. Ernst and Young, Beyond Borders: Global Biotechnology Report, 2008 (Cleveland: Ernst and Young, 2008).
3. Michael Hopkins, Paul Martin, Paul Nightingale, Alison Kraft, and Surya Mahdi, "The Myth of the Biotech Revolution: An Assessment of Technological, Clinical and Organizational Change," Research Policy 36 (2007), 584.
4. Juan Enriquez and Ray A. Goldberg, "Transforming Life, Transforming Business: The Life-Science Revolution," Harvard Business Review, March/April 2000, 97.
5. Johan Brink, Maureen McKelvey, and Keith Smith, "Conceptualizing and Measuring Modern Biotechnology," in The Economic Dynamics of Modern Biotechnology, ed. Maureen McKelvey, Annika Rickne, and Jens Laage-Hellman (Cheltenham, U.K.: Edward Elgar, 2004), 25.
6. Peter Singer, "Health Biotechnology Publishing Takes-off in Developing Countries," International Journal of Biotechnology 8 (2006), 31.
7. Wharton Business School, Wharton Healthcare Leadership Exchange (Philadelphia: Wharton Business School, February 2005), 12.
8. Winters, "The Determinants of Financial Crisis in Asia," in The Politics of the Asian Economic Crisis, ed. T. J. Pempel (Ithaca: Cornell University Press, 1999), 87.
9. Linda Weiss, "Guiding Globalisation in East Asia: New Roles for Old Developmental States," in States in the Global Economy: Bringing Domestic Institutions Back In, ed. Weiss (Cambridge: Cambridge University Press, 2003).
10. Robert Wade, Governing the Market: Economic Theory and the Role of Government in East Asian Industrialization (Princeton, N.J.: Princeton University Press, 1990).
11. Gregory Noble, Collective Action in East Asia: How Ruling Parties Shape Industrial Policy (Ithaca: Cornell University Press, 1998).
12. Peter Evans, Embedded Autonomy: States and Industrial Transformation (Princeton, N.J.: Princeton University Press, 1995).
13. Breznitz, Innovation and the State: Political Choice and Strategies for Growth in Israel, Taiwan and Ireland (New Haven, Conn.: Yale University Press, 2007), 14.
14. Linsu Kim, Imitation to Innovation: The Dynamics of Korea's Technological Learning (Boston: Harvard Business School Press, 1997).
15. Larry Westphal, Linsu Kim, and Carl Dahlman, "Reflections on the Republic of Korea's Acquisition of Technological Capability," in International Technology Transfer: Concepts, Measures and Comparisons, ed. Nathan Rosenberg and Claudio Frischtak (New York: Praeger, 1985).
16. Alice Amsden, Asia's Next Giant: South Korea and Late Industrialization (New York: Oxford University Press, 1989), 116-130.
17. Jung-En Woo, Race to the Swift: State and Finance in Korean Industrialization (New York: Columbia University Press, 1991).
18. Karl Fields, Enterprise and the State in Korea and Taiwan (Ithaca: Cornell University Press, 1995).
19. Eun Mee Kim, Big Business, Strong State: Collusion and Conflict in South Korean Development, 1960-1990 (Albany: SUNY Press, 1997), 110.
20. Mariko Sakakibara and Dong-Sung Cho, "Cooperative R&D in Japan and Korea: A Comparison of Industrial Policy," Research Policy 31 (2002), 685.
21. William Keller and Louis Pauly, "Crisis and Adaptation in Taiwan and South Korea: The Political Economy of Semiconductors," in Crisis and Innovation in Asian Technology, ed. William Keller and Richard Samuels (Cambridge: Cambridge University Press, 2003).
22. John Matthews and Dong-Sung Cho, Tiger Technology: The Creation of a Semiconductor Industry in East Asia (Cambridge: Cambridge University Press, 2000), 121-123.
23. Linsu Kim, "National Systems of Industrial Innovation: Dynamics of Capability Building in Korea," in National Innovation Systems: A Comparative Analysis, ed. Richard Nelson (New York: Oxford University Press, 1993), 377.
24. Yongping Wu, A Political Explanation of Economic Growth: State Survival, Bureaucratic Politics, and Private Enterprises in the Making of Taiwan's Economy, 1950-1985 (Cambridge, Mass.: Harvard University Press, 2005).
25. Suzanne Berger and Richard Lester, eds., Global Taiwan: Building Competitive Strengths in a New International Economy (Armonk, N.Y.: M. E. Sharpe, 2005).
26. Vincent Wang, "Developing the Information Industry in Taiwan: Entrepreneurial State, Guerilla Capitalists and Accommodative Technologists," Pacific Affairs 68 (1995).
27. Tun-Jen Cheng, "Political Regimes and Development Strategies: South Korea and Taiwan," in Manufacturing Miracles: Paths of Industrialization in Latin America and East Asia, ed. Gary Gereffi and Donald Wyman (Princeton, N.J.: Princeton University Press, 1990).
28. Constance Squires Meaney, "State Policy and the Development of Taiwan's Semiconductor Industry," in The Role of the State in Taiwan's Development, ed. Joel Aberbach, David Dollar, and Kenneth Sokoloff (Armonk, N.Y.: M. E. Sharpe, 1994).
29. Doug Fuller, Charles Sodini, and Akintunde Akinwande, "Leading, Following or Cooked Goose? Innovation Successes and Failures in Taiwan's Electronics Industry," in Global Taiwan: Building Competitive Strengths in a New International Economy, ed. Suzanne Berger and Richard Lester (Armonk, N.Y.: M. E. Sharpe, 2005).
30. Annalee Saxenian and Jinn-Yuh Hsu, "The Silicon Valley-Hsinchu Connection: Technical Communities and Industrial Upgrading," Industrial and Corporate Change 10 (2001).
31. Henry Wai-Chung Yeung, "State Intervention and Neoliberalism in the Globalizing World Economy: Lessons from Singapore's Regionalization Program," Pacific Review 13 (2001), 146.
32. David Chang, "Nation-Building in Singapore," Asian Survey 8 (1968).
33. Mike Hobday, Innovation in East Asia: The Challenge to Japan (Brookfield, Vt.: Edward Elgar, 1995), 140.
34. Linda Lim, "Singapore's Success: The Myth of the Free Market Economy," Asian Survey 23 (1983), 757.
35. W. G. Huff, "The Developmental State, Government and Singapore's Economic Development since 1960," World Development 23 (1995), 1428.
36. Florian von Alten, The Role of Government in the Singapore Economy (Frankfurt: Peter Lang, 1995), 200.
37. Linda Low, "The Singapore Developmental State in the New Economy and Polity," Pacific Review 14 (2001), 146.
38. Alexius Pereira, "Whither the Developmental State? Explaining Singapore's Continued Developmentalism," Third World Quarterly 29 (2008).
39. Gavin Peebles and Peter Wilson, Economic Growth and Development in Singapore (Cheltenham, U.K.: Edward Elgar, 2002), 14.
40. Kai-Sun Kwong, "Singapore: Dominance of Multinational Corporations," in Industrial Development in Singapore, Taiwan and South Korea, ed. Kwong et al. (Hackensack, N.J.: World Scientific Press, 2001), 10.
41. David McKendrick, Richard Doner, and Stephan Haggard, From Silicon Valley to Singapore: Location and Competitive Advantage in the Hard Disk Drive Industry (Stanford, Calif.: Stanford University Press, 2000), 37.
42. Alice Amsden and F. Ted Tschang, "A New Approach to Assessing the Technological Complexity of Different Categories of R&D (with examples from Singapore)," Research Policy 32 (2003).
43. Peter Evans, "Predatory, Developmental and Other Apparatuses: A Comparative Political Economy Perspective on the Third World State," Sociological Forum 4 (1989), 562-563.
44. Yun-Han Chu, "Surviving the East Asian Financial Storm," in The Politics of the Asian Economic Crisis, ed. T. J. Pempel (Ithaca: Cornell University Press, 1999), 201.
45. Frank Knight, Risk, Uncertainty and Profit (New York: Houghton Mifflin, 1921).
46. Branscomb and Auerswald, Taking Technical Risks: How Innovators, Executives and Investors Manage High-Tech Risks (Cambridge, Mass.: MIT Press, 2001), 44.
47. Alice Amsden and Wan-Wen Chu, Beyond Late Development: Taiwan's Upgrading Policies (Cambridge, Mass.: MIT Press, 2003).
48. Marie Anchordoguy, Reprogramming Japan: The High-Tech Crisis under Communitarian Capitalism (Ithaca: Cornell University Press, 2005).
49. Poh-Kam Wong, "Singapore's Technology Strategy," in The Emerging Technological Trajectory in the Pacific Rim, ed. Denis Fred Simon (Armonk, N.Y.: M. E. Sharpe, 1995).
50. Alice Amsden, Asia's Next Giant: South Korea and Late Industrialization (New York: Oxford University Press, 1989).
51. Gary Pisano, Science Business: The Promise, the Reality and the Future of Biotech (Boston: Harvard Business School Press, 2006), 7-8.
52. Johan Brink, Maureen McKelvey, and Keith Smith, "Conceptualizing and Measuring Modern Biotechnology," in The Economic Dynamics of Modern Biotechnology, ed. Maureen McKelvey, Annika Rickne, and Jens Laage-Hellman (Northampton, Mass.: Edward Elgar, 2004).
53. John Kay, "Technology and Wealth Creation: Where We Are and Where We're Going," Other, December 19, 2000.
54. J. S. Metcalfe, "Science Policy and Technology Policy in a Competitive Economy," International Journal of Social Economics 24 (1997), 728.
55. Kevin Murphy and Robert Topel, eds., Measuring the Gains from Medical Research: An Economic Approach (Chicago: University of Chicago Press, 2003).
56. Partha Dasgupta and Paul David, "Toward a New Economics of Science," Research Policy 23 (1994), 490.
57. Kenneth Arrow, "Economic Welfare and the Allocation of Resources for Inventions," in The Rate and Direction of Inventive Activity, ed. Richard Nelson (Princeton, N.J.: Princeton University Press, 1962).
58. Evan Berman, "The Economic Impact of Industry-Funded University R&D," Research Policy 19 (1990).
59. Seongjae Yu, "Korea's High Technology Thrust," in The Emerging Technological Trajectory of the Pacific Rim, ed. Denis Simon (Armonk, N.Y.: M. E. Sharpe, 1995), 85.
60. G. Dosi, "Technological Paradigms and Technological Trajectories: A Suggested Interpretation of the Determinants and Directions of Technological Change," Research Policy 11 (1982).
61. Michael Hopkins, Paul Martin, Paul Nightingale, Alison Kraft, and Surya Mahdi, "The Myth of the Biotech Revolution: An Assessment of Technological, Clinical and Organisational Change," Research Policy 36 (2007), 568.
62. Maureen McKelvey, Annika Rickne, and Jens Laage-Hellman, eds., The Economic Dynamics of Modern Biotechnology (Northampton, Mass.: Edward Elgar, 2004).
63. Robert Kaiser and Heiko Prange, "The Reconfiguration of National Innovation Systems: The Example of German Biotechnology," Research Policy 33 (2004).
64. Susanne Giesecke, "The Contrasting Roles of Government in the Development of Biotechnology Industry in the US and Germany," Research Policy 29 (2000).
65. Orsenigo, "The Dynamics of Competition in a Science-Based Technology: The Case of Biotechnology," in Technology and the Wealth of Nations, ed. Dominique Foray and Christopher Freeman (New York: Pinter, 1993), 43.
66. Ingrid Wickelgren, The Gene Masters: How a New Breed of Scientific Entrepreneurs Races for the Biggest Prize in Biology (New York: Times Books, 2002).
67. Richard Nelson, ed., National Innovation Systems (New York: Oxford University Press, 1993).
68. Donald Stokes, Pasteur's Quadrant: Basic Science and Technological Innovation (Washington, D.C.: Brookings Institution, 1997).
69. J. Rogers Hollingsworth, "Doing Institutional Analysis: Implications for the Study of Innovations," Review of International Political Economy 7 (2000).
70. Steven Casper, Creating Silicon Valley in Europe: Public Policy towards New Technology Industries (New York: Oxford University Press, 2007).
71. Daniele Archibugi and Simona Iammarino, "The Policy Implications of the Globalization of Innovation," Research Policy 28 (1999).
72. Michael Porter, "Clusters and the New Economics of Competition," Harvard Business Review, November-December 1998.
73. Peter Hall and David Soskice, eds., Varieties of Capitalism: The Institutional Foundations of Comparative Advantage (New York: Oxford University Press, 2001).
74. Mark Zachary Taylor, "Empirical Evidence against Varieties of Capitalism's Theory of Technological Innovation," International Organization 58 (2004).
75. Dirk Akkermans, Carolina Castaldi, and Bart Los, "Do 'Liberal Market Economies' Really Innovate More Radically than 'Coordinated Market Economies'? Hall and Soskice Reconsidered," Research Policy 38 (2009).
76. David Mowery, Richard Nelson, Bhaven Sampat, and Arvids Ziedonis, eds., Ivory Tower and Industrial Innovation: University-Industry Technology Transfer Before and After the Bayh-Dole Act in the United States (Stanford, Calif.: Stanford University Press, 2004).
77. Jeannette Colyvas, "From Divergent Meanings to Common Practices: The Early Institutionalization of Technology Transfer in the Life Sciences at Stanford University," Research Policy 36 (2007), 474.
78. Bengt-Ake Lundvall, ed., National Systems of Innovation: Towards a Theory of Innovation and Interactive Learning (London: Pinter, 1992), 8.
79. Dani Rodrik, One Economics, Many Recipes: Globalization, Institutions and Economic Growth (Princeton, N.J.: Princeton University Press, 2007), 164.
80. Daniel Kahneman and Amos Tversky, "Judgment under Uncertainty: Heuristics and Biases," Science 185 (1974).
81. David Moss, When All Else Fails: Government as the Ultimate Risk Manager (Cambridge, Mass.: Harvard University Press, 2004), 40-41.
82. Lawton Robert Burns, ed., The Business of Healthcare Innovation (New York: Cambridge University Press, 2005).
83. Richard Oliver, The Coming Biotech Age: The Business of Bio-Materials (New York: McGraw- Hill, 2000).
84. Yun-Han Chu, "Surviving the East Asian Financial Storm: The Political Foundation of Taiwan's Economic Resilience," in The Politics of the Asian Economic Crisis, ed. T. J. Pempel (Ithaca: Cornell University Press, 1999).
85. Danny Lam and Ian Lee, "Guerilla Capitalism and the Limits of Statist Theory: Comparing the Chinese NICs," in The Evolving Pacific Basin in the Global Political Economy, ed. Cal Clark and Steve Chan (Boulder, Colo.: Lynne Rienner, 1992), 111-113.
86. Vincent Wang, "Developing the Information Industry in Taiwan: Entrepreneurial State, Guerilla Capitalists and Accommodative Technologists," Pacific Affairs 68 (1995), 572-574.
87. Wen-Hsiung Lee and Wei-Tzen Yang, "The Cradle of Taiwan's High Technology Industry Development: Hsinchu Science Park (HSP)," Technovation 20 (2000), 570.
88. Dan Breznitz, Innovation and the State: Political Choice and Strategies for Growth in Israel, Taiwan and Ireland (New Haven, Conn.: Yale University Press, 2007).
89. Richard Nelson, ed., National Innovation Systems: A Comparative Analysis (New York: Oxford University Press, 1993).
90. AnnaLee Saxenian, "Taiwan's Hsinchu Region: Imitator and Partner for Silicon Valley," SIEPR Discussion Paper No. 00-44, 2001, 11.
91. Haider Khan, Interpreting East Asian Growth and Innovation: The Future of Miracles (New York: Palgrave Macmillan, 2004).
92. Robert Yuan, "Scinopharm Focuses on Manufacturing of APIs," Genetic Engineering News 22 (March 15, 2002).
93. Scinopharm press release, "Scinopharm's 2006 Revenue and Net Income at Record High," February 26, 2007. See http://www.scinopharm.com (accessed March 5, 2007).
94. Pao-Long Chang and Chiung- Wen Hsu, "A Stage Approach for Industrial Technology Development and Implementation," Technovation 19 (1999).
95. Matthews, "The Origins and Dynamics of Taiwan's R&D Consortia," Research Policy 31 (2002), 635.
96. Dodgson, John Matthews, Mei-Chih Hu, and Tim Kastelle, "The Changing Nature of Innovation Networks in Taiwan: From Imitation to Innovation?" (paper presented at the annual DRUID conference, Copenhagen, Denmark, June 18-20, 2006), 7.
97. Min-Ping Huang, "The Cradle of Technology: The Industrial Technology Research Institute," in The Silicon Dragon: High-Tech Industry in Taiwan, ed. Terence Tsai and Bor-Shiuan Cheng (Northampton, Mass.: Edward Elgar, 2006).
98. Steven Casper, Creating Silicon Valley in Europe: Public Policy toward New Technology Industries (New York: Oxford University Press, 2007).
99. John Matthews and Dong-Sung Cho, Tiger Technology: The Creation of a Semiconductor Industry in East Asia (New York: Cambridge University Press, 2000).
100. Joonghae Suh, "Korea's Innovation System: Challenges and New Policy Agenda," INTECH Discussion Paper Series, 2000.
101. Linsu Kim, "National Systems of Industrial Innovation: Dynamics of Capability Building in Korea," in National Innovation Systems, ed. Richard Nelson (New York: Oxford University Press, 1993).
102. Ministry of Science and Technology (MOST), National Science and Technology Statistical Indicators (Seoul: MOST, 2002).
103. Meredith Woo-Cumings, "The State, Democracy and the Reform of the Corporate Sector in Korea," in The Politics of the Asian Economic Crisis, ed. T. J. Pempel (Ithaca: Cornell University Press, 1999), 122, 141.
104. BPRC, Status of Biotechnology, 18.
105. Eun Mee Kim, Big Business, Strong State: Collusion and Conflict in South Korean Development, 1960-1990 (Albany: SUNY Press, 1997).
106. Soon Il Ahn, "A New Program in Cooperative Research between Academia and Industry in Korea, Involving Centers of Excellence," Technovation 15 (1995).
107. S. Chung, "Building a National Innovation System through Regional Innovation Systems," Technovation 22 (2002).
108. Joseph Wong, "From Learning to Creating: Biotechnology and the Postindustrial Developmental State in Korea," Journal of East Asian Studies 4 (2004).
109. Molly Webb, South Korea: Mass Innovation Comes of Age (London: Demos, 2007).
110. Ministry of Science and Technology (MOST), Bio-Vision 2016 (Seoul: MOST, 2007), 13.
111. Webb, South Korea: Mass Innovation, 18.
112. Mariko Sakakibara and Dong-Sung Cho, "Cooperative R&D in Japan and Korea: A Comparison of Industrial Policy," Research Policy 31 (2002).
113. Dong-Sung Cho, Eunjung Hyun, and Soo Hee Lee, "Can Newly Industrializing Economies Catch Up in Science-Based Industries? A Study of the Korean Biotechnology Sector," Journal of Interdisciplinary Economics 18 (2007).
114. Cynthia Fox, Cell of Cells: The Global Race to Capture and Control the Stem Cell (New York: Norton, 2007).
115. Kai-Sun Kwong, "Singapore: Dominance of Multinational Corporations," in Industrial Development in Singapore, Taiwan and South Korea, ed. Kwong et al. (Hackensack, N.J.: World Scientific Press, 2001).
116. Govindan Parayil, "From 'Silicon Island' to 'Biopolis of Asia,' " California Management Review 47 (2005), 63.
117. Economic Development Board, Biomedical Sciences: Factsheet 2010, available at http://www.sedb.com (accessed October 15, 2010).
118. Ai-Lien Chang and Daryl Loo, "How a Perfect Marriage Fell Apart," Straits Times, August 13, 2006.
119. Ernst and Young, Beyond Borders: Global Biotechnology Report, 2008 (Cleveland: Ernst and Young, 2008), 105.
120. Mark Goh and Irene Chew, "Public Policy and Entrepreneurship Development-Singapore Style," Journal of Enterprising Culture 4 (1996), 88.
121. Check-Teck Foo and Check-Tong Foo, "Socialization of Technopreneurism: Towards Symbiosis in Corporate Innovation and Technology Strategy," Technovation 20 (2000), 561.
122. Winston Koh and Poh-Kam Wong, "The Venture Capital Industry in Singapore," NUS Entrepreneurship Centre, Working Papers, 2005.
123. Robert Wade, Governing the Market: Economic Theory and the Role of Government in East Asian Industrialization (Princeton, N.J.: Princeton University Press, 1990), 28.
124. Jim Boyce, "Taiwan's Biotech Clock Ticking . . . " Topics: The Magazine of International Business in Taiwan 32 (2002).
125. Dan Nystedt, "Chen Asks Foreigners to Help in Building Biotech," Taipei Times, August 7, 2001.
126. Michael Hopkins, Paul Martin, Paul Nightingale, Alison Kraft, and Surya Mahdi, "The Myth of the Biotech Revolution: An Assessment of Technological, Clinical and Organizational Change," Research Policy 36 (2007), 586.
127. Ming-Ling Hsieh, "Taiwan's Biotech Outbreak," Commonwealth Magazine, August 15, 2007.
128. Alexius Pereira, "Whither the Developmental State? Explaining Singapore's Continued Developmentalism," Third World Quarterly 29 (2008), 1196.
129. Mia Shanley, "Maverick Singapore Bureaucrat Hunts for Scientists," Reuters News, February 17, 2006.
130. National Science Council (NSC), Indicators of Science and Technology 2002 (Taipei: NSC, 2002), 110-117.
131. Ming-Ling Hsieh, "Taiwan's Biotech Dream Team," Commonwealth Magazine, September 26, 2007.
132. Jessica Cheam, "Biogenesis: Potential Stem Cell Venture," Straits Times, August 13, 2005.
133. John Burton, "ES Cell International: In Singapore, a Company with Ambitious Goals Leads a 'Privileged Existence,' " Scientific American, June 27, 2005.
134. Norimitsu Onishi, "In a Country That Craved Respect, Stem Cell Scientist Rode a Wave of Korean Pride," New York Times, January 22, 2006.
135. Nicholas Wade, "Clone Scientist Relied on Peers and Korean Pride," New York Times, December 25, 2005.
136. Joseph Wong, "Korea's Stem Cell Debacle: How a Nation's Disgrace Can Ultimately Be Its Victory," Munk Centre Monitor (2006).
137. David Kang and Adam Segal, "The Siren Song of Technonationalism," Far Eastern Economic Review, March 2006.
138. Francis Fukuyama, Our Posthuman Future: Consequences of the Biotechnology Revolution (New York: Farrar, Straus and Giroux, 2002).
139. Nicholas Wade and Sang-Hun Choe, "Researcher Faked Evidence of Human Cloning, Koreans Report," New York Times, January 10, 2006.
140. Cynthia Fox, Cell of Cells: The Global Race to Capture and Control the Stem Cell (New York: W. W. Norton, 2008), 462.
141. David Levi-Faur, "Governing Dutch Telecommunications Reform," Journal of European Public Policy 6 (1999), 119.
142. Stephen J. Ceccoli, Pill Politics: Drugs and the FDA (Boulder, Colo.: Lynne Rienner, 2004).
143. Ernst and Young, Beyond Borders: Global Biotechnology Report, 2008 (Cleveland: Ernst and Young, 2008), 92.
144. Mary Ellen Rosenberg, "Implementing GCPs in Asia," Quality Assurance Journal 4 (2000).
145. In-Jin Jang, "Regulatory Perspectives and Clinical Trial Status in South Korea" (paper presented at the 6th Kitasato University-Harvard School of Public Health Symposium on Advanced and Global Drug Development Techniques, Tokyo, Japan, October 2005).
146. Bioethics Advisory Committee, "Advancing the Framework of Ethics Governance for Human Research, Annex B," Consultation Paper, Singapore, September 16, 2003.
147. Herng-Der Chern, Ing-Tiau Kuo, Low-tong Ho, Hsin-Nan Lin, and Sheng-Muo Hou, "The Joint Institutional Review Board in Taiwan," Drug Information Journal 32 (1998).
148. Ock-Joo Kim, "Current Status of Institutional Review Boards in Korea: Constitution, Operation and Policy for Protection of Human Research Participants," Journal of Korean Medical Science 18 (2003).
149. Faiz Keramnia and Rory Gallagher, "The Promise of Korea," Applied Clinical Trials (2005).
150. Piero Olliaro, Ramani Vijayan, K. Inbasegaran, Chim Choy Lang, and Sornchai Looareesuwan, "Drug Studies in Developing Countries," Bulletin of the World Health Organization 79 (2001).
151. Sandra Ho-Lin Jao, Herng-Der Chern, and Mong-Ling Chu, "Reinventing Drug Regulation in the Asia Pacific Region: Taiwan's Experience and Vision for the Region," Drug Information Journal Supplement 37 (2003).
152. Hui-Po Wang and Sue Shu-Yi Chen, "Clinical Trials in Taiwan: Regulatory Achievements and Current Status," Drug Information Journal Supplement 37 (2003).
153. Ellick Wong, "The Regulatory Environment and Clinical Trials in Southeast Asia," Drug Information Journal Supplement 37 (2003).
154. Ernst and Young, Beyond Borders, 92.
155. Tan Shook Fong, "Development of Clinical Trials in Singapore," Drug Information Journal 32 (1998).
156. Health Sciences Authority, "Creating Value," Annual Report of the Health Sciences Authority (Government of Singapore, 2005).
157. Jen-Pei Liu, "The Integrated Clinical and Statistical Report for Registration in Taiwan," Drug Information Journal 32 (1998).
158. Korean Food and Drug Administration, KFDA Database, 2006, available at http://www.kfda.go.kr (accessed March 2008).
159. Gerd Gigerenzer, Wolfgang Gaissmaier, Elke Kurz-Milcke, Lisa M. Schwartz, and Steven Woloshin, "Helping Doctors and Patients Make Sense of Health Statistics," Psychological Science 8 (2008).
160. Stephane Jacobzone, "Pharmaceutical Policies in OECD Countries: Reconciling Social and Industrial Goals," Labour Market and Social Policy Occasional Papers, No. 40 (2000), 9.
161. Bruce Einhorn, Jennifer Veale, and Manjeet Kripalani, "Asia Is Stem Cell Central," Businessweek, January 10, 2005.
162. Lisa Krieger, "As the US Hesitates, Other Countries Move Ahead with Embryo Research," available at http://www.siliconvalley.com/mld/ siliconvalley/news/3210920.htm (accessed July 2006).
163. UK Stem Cell Initiative, "Global Positions in Stem Cell Research: Taiwan," available at http://www.advisorybodies.doh.gov.uk/uksci/global/taiwan.htm (accessed November 2006).
164. Dennis Normile and Charles Mann, "Asia Jockeys for Stem Cell Lead," Science 307 (2005).
165. "DOH Announces Regulations on Stem Cell Research," United Daily News (Taiwan), February 20, 2002.
166. Chueh-An Yen, "Full Public Discussion Needed on DNA Bank," Taipei Times, February 6, 2006, 8.
167. Keun-Min Bae, "Bioethics Law May Face Court Review," Korea Times, January 6, 2005.
168. Bioethics Advisory Committee, "Ethical, Legal and Social Issues in Stem Cell Research, Reproductive and Therapeutic Cloning," A Report from the Bioethics Advisory Committee (Government of Singapore, June 2002).
169. David Cyranowski, "Korea's Stem Cell Stars Dogged by Suspicion of Ethical Breach," Nature, May 6, 2004.
170. Dennis Normile, "South Korea Picks Up the Pieces," Science, June 2, 2006.
171. Herbert Gottweis and Robert Triendl, "South Korean Policy Failure and the Hwang Debacle," Nature Biotechnology 24 (2006).
172. Mildred Cho, Glenn McGee, and David Magnus, "Lessons of the Stem Cell Scandal," Science, February 3, 2006.
173. Sung-Goo Han, Young Je You, and Wha-Joon Rho, "New Cloning Technologies and Bioethics Issues: The Legislative Process in Korea," Journal of Asian and International Bioethics 13 (2003).
174. Edison Liu, "Can It Happen in Singapore?" Straits Times, December 30, 2005.
175. Soonman Kwon, "Technology and Health Policy: Rapid Technology Diffusion and Policy Options in Korea" (paper presented at Canada-Korea Social Policy Symposium, Toronto, January 27-28, 2005).
176. Hui-Po Wang, "Pharmaceutical Regulatory Affairs of Chinese Taipei" (presentation at the APEC LSIF Readiness Assessment Pilot Project, September 7, 2004).
177. Joseph Wong, Healthy Democracies: Welfare Politics in Taiwan and South Korea (Ithaca: Cornell University Press, 2004).
178. Bong-Min Yang, "Health Care Reform in South Korea: Any Lessons from Canada?" (paper presented at the Canada-Korea Social Policy Symposium, Toronto, January 27-28, 2005).
179. David Banta, "The Development of Health Technology Assessment," Health Policy 63 (2003).
180. Jo Hsieh, Lillian Wang, and Jason Heng-Shu Chen, "The Future of Pharmacoeconomics and Outcomes Research in Asia," Drug Information Journal Supplement 37 (2003).
181. Asia-Pacific Biotech News, "Taiwan Asked to Revise Pharmaceutical Pricing Policy," APBN Newsletter 1, 30 (1998).
182. Pacific Bridge Medical (PBM), 1999 Regulatory Update: South Korea's Medical Device and Pharmaceutical Markets (July 1, 1999).
183. USTR (United States Trade Representative), "Taiwan," USTR Report, 2005, available at http://www.ustr.gov/assets/Document_ Library/Reports_Publications/2005/2005_NTE_Report/asset_upload_file101_7501.pdf (accessed June 2006).
184. American Chamber of Commerce in Taiwan, AmCham 2003 Taiwan White Paper: Pharmaceuticals (Taipei: American Chamber of Commerce, 2003).
185. Tsung-Mei Cheng, "Taiwan's New National Health Insurance Program: Genesis and Experience So Far," Health Affairs 22 (2003), 68.
186. Y. J. Chou, Winnie C. Yip, Cheng-Hua Lee, Nicole Huang, Ying-Pei Sun, and Hong- Jen Chang, "Impact of Separating Drug Prescribing and Dispensing on Provider Behavior: Taiwan's Experience," Health Policy and Planning 18 (2003).
187. Pacific Bridge Medical (PBM), Asian Medical Newsletter 2 (2002).
188. Ernst and Young, Beyond Borders, 5-7.
189. Halla Thorsteinsdottir, Uyen Quach, Abdallah Daar, and Peter Singer, "Conclusion: Promoting Biotechnology Innovation in Developing Countries," Nature Biotechnology 22 (2004).
190. "The Export Trap," Economist, March 25, 2009.
191. Shahid Yusuf, Innovative East Asia: The Future of Growth (New York: Oxford University Press; Washington, D.C.: World Bank, 2003).
192. Richard Doner, Allen Hicken, and Bryan Ritchie, "Political Challenges of Innovation in the Developing World," Review of Research Policy 26 (2009), 152.
193. Philip Cerny, "Globalization and the Changing Logic of Collective Action," International Organization 49 (1995).
194. Dani Rodrik, One Economics, Many Recipes: Globalization, Institutions, and Economic Growth (Princeton, N.J.: Princeton University Press, 2007), 164.
195. Dan Breznitz, Innovation and the State: Political Choice and Strategies for Growth in Israel, Taiwan and Ireland (New Haven, Conn.: Yale University Press, 2007), 207.
196. Dan Breznitz, "National Institutions and the Globalized Political Economy of Technological Change: An Introduction," Review of Research Policy 26 (2009).
197. David Moss, When All Else Fails: Government as the Ultimate Risk Manager (Cambridge, Mass.: Harvard University Press, 2002), 42-45.
198. Meredith Woo-Cumings, "The State, Democracy and the Reform of the Corporate Sector in Korea," in The Politics of the Asian Economic Crisis, ed. T. J. Pempel (Ithaca: Cornell University Press, 1999), 117.
199. T. J. Pempel, ed., The Politics of the Asian Economic Crisis (Ithaca: Cornell University Press, 1999).
200. Breznitz, Innovation and the State, 29.
201. Halla Thorsteinsdottir, Abdallah Daar, and Peter Singer, "Health Biotechnology Publishing Takes-off in Developing Countries," International Journal of Biotechnology 8 (2006), 34-35.
202. Joseph Wong, "Biotechnology in Hong Kong: Prospects and Challenges," in Innovation Policy and the Limits of Laissez-Faire: Hong Kong's Policy in Comparative Perspective, ed. Douglas Fuller (Basingstoke, U.K.: Palgrave Macmillan, 2010).
203. David Guston, Between Politics and Science: Assuring the Integrity and Productivity of Research (New York: Cambridge University Press, 2000).